Somatropin half-life runs about 3 to 5 hours after a subcutaneous dose and 20-30 minutes IV. Learn what changes clearance and how long it stays in your system.
Somatropin has a short half-life: roughly 20 to 30 minutes when given intravenously and about 3 to 5 hours after a subcutaneous injection. That short window is the main reason somatropin is dosed daily rather than weekly, and it is why the hormone clears from the blood long before its biological effects fade. The somatropin half-life describes how long the drug itself lingers, not how long its downstream effects last.
What Somatropin Is and Why Half-Life Matters
Somatropin is recombinant human growth hormone (rhGH), a 191-amino-acid protein made with recombinant DNA technology. Its sequence matches growth hormone produced by the pituitary gland, and it is sold under brand names such as Genotropin, Humatrope, Norditropin, Omnitrope, Saizen, and Serostim.
Because somatropin is a protein, it is not processed by the liver's CYP450 enzymes the way most small-molecule drugs are. It is instead broken down into amino acids in the liver, kidneys, and peripheral tissues. That difference explains why its elimination is fast and why few drugs interact with it through metabolism.
- Half-life is the time it takes for plasma concentration to fall by half.
- Elimination half-life describes clearance of the drug itself.
- Biological effect usually lasts much longer, because growth hormone works largely through IGF-1.
Somatropin Half-Life by Route of Administration
Route of administration changes the number dramatically. Intravenous somatropin is cleared within minutes, while subcutaneous dosing stretches the apparent half-life into hours because absorption becomes the rate-limiting step.
| Route | Approximate half-life | Notes |
|---|---|---|
| Intravenous (IV) | 20-30 minutes | Fastest clearance; used mainly in research and stimulation testing. |
| Intramuscular (IM) | 2-4 hours | Faster absorption than subcutaneous; less common for routine therapy. |
| Subcutaneous (SC) | 3-5 hours | Standard therapeutic route; product labeling often cites about 3 hours. |
After a subcutaneous injection, peak blood levels typically appear about 3 to 5 hours later. Some product labeling cites an apparent half-life closer to 3 hours, while clinical reviews commonly quote 3 to 5 hours, depending on the assay and the population studied.
Half-Life vs. How Long Somatropin Stays in Your System
A short half-life does not mean a short effect. Growth hormone signals the liver and other tissues to release insulin-like growth factor 1 (IGF-1), which has its own half-life of roughly 12 to 15 hours and circulates bound to carrier proteins that extend its activity.
The IGF-1 Effect
After a single subcutaneous dose, IGF-1 levels can stay elevated for 24 hours or more. Clinicians therefore monitor IGF-1 rather than growth hormone itself when adjusting therapy, and they typically wait days rather than hours before rechecking a level.
Typical Detection Windows
For most people, a subcutaneous dose of somatropin is largely cleared within 12 to 24 hours, although traces may be detectable slightly longer. The exact answer to how long does somatropin stay in your system depends on dose, injection site, body composition, and kidney and liver function.
- Serum growth hormone: usually measurable for up to about 24 hours after a subcutaneous dose.
- Urine growth hormone metabolites: a shorter window, generally on the order of a day or two.
- IGF-1 as a biomarker: elevated for days to weeks, which makes it the more useful long-window indicator in clinical and anti-doping settings.
Anti-doping programs rely on isoform-differential immunoassays rather than standard drug panels, because routine workplace or clinical urine screens do not test for growth hormone at all.
What Changes Somatropin Half-Life and Clearance
Individual pharmacokinetics vary, and small differences in how a dose is given can shift the numbers.
- Injection site and subcutaneous fat: absorption is slower from thicker fat layers, which can flatten and extend the concentration curve.
- Dose size: larger doses take longer to clear completely, even though the half-life itself stays roughly the same.
- Formulation: lyophilized powders, liquid pen devices, and depot products differ in how quickly somatropin reaches circulation.
- Age and body weight: clearance tends to be slower in older adults and in people with more adipose tissue.
- Renal or hepatic impairment: protein breakdown pathways can slow, extending exposure.
- Anti-drug antibodies: uncommon, but they can alter clearance and reduce response in some patients.
How Somatropin Compares With Other Peptides
Half-life is the single biggest driver of how often any peptide is dosed. The hgh half life is the same measurement described on this page, because somatropin and human growth hormone are the same molecule.
For contrast, the dsip half life is measured in minutes, and the epitalon half life is similarly brief, which is why those compounds are studied with frequent or pulsed administration. Early work on the mots-c half-life points to a short window as well, while the pt-141 half-life of roughly 2.7 hours sits much closer to somatropin's range.
| Compound | Reported half-life (approximate) | Typical route studied |
|---|---|---|
| Somatropin (rhGH) | 3-5 hours | Subcutaneous |
| DSIP | Minutes | Intravenous |
| Epitalon | Minutes | Intravenous |
| MOTS-c | Short (preclinical data) | Injection, preclinical |
| PT-141 (bremelanotide) | About 2.7 hours | Subcutaneous |
| SS-31 (elamipretide) | Short; roughly an hour in IV studies | Intravenous |
Longevity research often groups peptides with other molecules, and topics such as life extension glutathione come up in the same conversations, but half-life, route, and evidence quality differ so widely between compounds that the categories should not be treated as interchangeable.
Safety, Legality, and Monitoring
In the United States, somatropin is a prescription-only product approved for specific conditions, including pediatric and adult growth hormone deficiency, Turner syndrome, growth failure related to chronic kidney disease, and short stature from certain causes. Somatropin is not FDA-approved for anti-aging, athletic performance, or weight loss in healthy adults, and distributing it for those purposes is illegal.
Common side effects include injection site reactions, fluid retention, joint and muscle pain, headache, and elevated blood sugar. More serious risks include intracranial hypertension, worsening of diabetic retinopathy, and tumor-related concerns in people with a history of malignancy.
Prescribed somatropin requires ongoing monitoring of IGF-1, blood glucose, and thyroid function. A healthcare professional should review any other medication, supplement, or peptide used at the same time, and no one should start or adjust somatropin without medical supervision.
Frequently Asked Questions
How long does somatropin stay in your system?
After a subcutaneous injection, somatropin is largely cleared within 12 to 24 hours, though low levels may be detectable for slightly longer. IGF-1, the main downstream hormone, stays elevated for 24 hours or more and can remain abnormal for days to weeks. Dose, injection site, body composition, and kidney or liver function all affect the timeline.
What is the half-life of somatropin?
Somatropin's half-life is roughly 20 to 30 minutes after an intravenous dose and about 3 to 5 hours after a subcutaneous injection. The subcutaneous number is an apparent half-life, because slow absorption from tissue is the rate-limiting step. Product labeling often cites a value near 3 hours.
Can somatropin be detected on a drug test?
Standard urine drug panels used by employers and most clinics do not screen for growth hormone. Anti-doping agencies use specialized isoform-differential immunoassays that can detect injected growth hormone for roughly a day, plus IGF-1 markers that stay abnormal far longer. Detection windows vary by dose, timing, and the specific test used.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.